Cantos Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.
BiotechHealthtechAustin, US
Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)
BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)
Co-investorsAble PartnersAtacama VenturesCota CapitalFuture VenturesiSelect FundS2G Investments+4 more
Earth AI uses AI to locate critical mineral deposits by analyzing geological data, supporting the supply chain for hardware and emerging technologies.
Advanced ManufacturingAI & Machine LearningClimate TechDeep TechNew MaterialsSan Francisco, US
Roman Teslyuk(Founder)in
BoardMikhail Taver(Director)Jamie Lee(Director)inIsabella Sykes(Director)Arnoud Balhuizen(Director)
Board seatIan Rountree· per SEC Form D
Co-investorsAirTree VenturesAlpaca VCBlackbird VenturesCorigin VenturesDCVC (Data Collective)Deep Acre+12 more
Vital Lyfe makes a portable watermaker called Access that converts any naturally occurring water, including saltwater, into clean drinking water through a three-step process.
CleantechClimate TechConsumerHardwareHawthorne, US
Andrew Harner(Founder)inJon C(Founder)Jon C.(Founder)inCharles Andrew Harner(Executive Officer, Director)Jonathan Criss(Executive Officer, Director)in
BoardAchal Upadhyaya(Director)
Co-investorsGeneral CatalystInterlagos
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.